In this interactive, CME/CE/CPE-certified video module, Jonathan Scott Coblyn, MD; Jessica Farrell, PharmD; and Frances Griffin, RN, BSN, provide multidisciplinary perspectives on best practices in the use of traditional, biologic, and targeted synthetic DMARD monotherapy to treat rheumatoid arthritis.
In this downloadable slideset, Jonathan Scott Coblyn, MD; Jessica Farrell, PharmD; and Frances Griffin, RN, BSN, provide an overview of best practices in the use of monotherapy to treat rheumatoid arthritis.
Here’s my take on the patients who are best suited to receive biologic or targeted synthetic DMARD monotherapy.
What are the data supporting the use of newer agents as monotherapy for patients with RA? Here’s my take.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.